All In Biotech

Drug Trial Radar · NCT07913061

A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin

A Multicenter, Randomized, Open-Label, Parallel-Group, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin, With or Without Non-Insulin Antidiabetic Drugs

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 680 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

680

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Jan 2028

Study completion Feb 2028

Sponsor

Sponsor type
Industry
First posted
Nov 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate efficacy and safety of once-weekly SHR-3167 and once-daily Insulin Degludec in participants with Type 2 diabetes that has been treated with basal insulin. The study consists of a screening period, a treatment period and a safety follow-up period. The study will last up to 33 weeks.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • SHR-3167Drug

    SHR-3167.

  • insulin degludecDrug

    Insulin degludec.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Glycated Hemoglobin A1c (HbA1c) (Non-inferiority)Time frame: From baseline to Week 26.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The Third Affiliated Hospital of Sun Yat-sen University

    Shenzhen, Guangdong, China

  • Zhongshan Hospital Affiliated to Fudan University

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.